Knowledge and opinions regarding BRCA1 and BRCA2 genetic testing among primary care physicians
Erin W Dekanek1, Darcy L Thull2, Mylynda Massart3
1Department of Human Genetics, University of Pittsburgh, Pittsburgh, PA, USA.
Primary care providers show moderate knowledge of BRCA1/2 testing for hereditary breast and ovarian cancer syndrome. Educational efforts are needed to improve their readiness for incorporating genetic testing into practice.
Area of Science:
- Oncology
- Genetics
- Primary Care Medicine
Background:
- BRCA1 and BRCA2 (BRCA1/2) testing is crucial for hereditary breast and ovarian cancer syndrome.
- Expanding indications necessitate integrating genetic services into primary care.
Purpose of the Study:
- Evaluate primary care providers' knowledge and opinions on BRCA1/2 testing.
- Identify barriers and motivators for implementing genetic testing in primary care.
Main Methods:
- Survey distributed to Obstetrics/Gynecology and Family Medicine physicians.
- 86 physicians completed the survey between July and September 2015.
- Assessed knowledge and confidence levels regarding BRCA1/2 testing.
Main Results:
- Average correct response rate to knowledge questions was 73%.
- Approximately 50% of respondents felt somewhat confident providing BRCA1/2 information.
- Physicians perceived genetic specialists and oncologists as most qualified for genetic services.
Conclusions:
- Primary care providers are not uniformly prepared for BRCA1/2 genetic testing.
- Professional guidelines and evidence of utility may encourage adoption.
- Findings will inform educational initiatives for non-genetic professionals.
More Related Videos
08:53Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
Published on: February 17, 2011
13:04In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
Published on: October 14, 2015
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Clinical Trials: Overview
Cancer Prevention
Some...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Clinical Trials
There are four phases in a clinical trial. A phase one...
